KalVista plummets following discontinuation of KOMPLETE trial Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Poshmark (POSH) up 13% after Naver Corp. and the company announced that they have entered into a definitive agreement under which Naver will acquire all of the issued and outstanding shares of Poshmark for $17.90 in cash
- Adeia (ADEA) up 10% after completing its transformation to become an independent intellectual property licensing company, following completion of the spin-off of its product business
- Rivian Automotive (RIVN) up 7% after announcing it produced 7,363 vehicles at its manufacturing facility in Illinois and delivering 6,584 vehicles during Q3
- Tesla (TSLA) up 2% after Cathie Wood's ARK Investment bought 132.2K shares of the stock last night
- Bed Bath & Beyond (BBBY) up 2% after The Wall Street Journal reported that some Bed Bath & Beyond bondholders are working with Perella Weinberg Partners ahead of debt talks expected to be held with the company
- Exelixis (EXEL) up 2% after announcing the expansion of its June 2021 clinical trial collaboration and supply agreement with Bristol-Myers Squibb Company (BMY) to include the use of the fixed-dose combination of nivolumab and relatlimab in the ongoing phase 1b STELLAR-002 clinical trial
UP AFTER EARNINGS -
- Acuity Brands (AYI) up 7%
LOWER -
- KalVista (KALV) down 53% after terminating the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary angioedema
- AXT Inc. (AXTI) down 8% after cutting its Q3 revenue outlook
- Rocket Pharmaceuticals (RCKT) down 1% after a 6.8M share secondary offering priced at $14.75
Symbols:
TSLA POSH ADEA EXEL BBBY RIVN AYI KALV RCKT AXTI Keywords: Fly Intel, Wall Street, Top Stories, Stocks